Skip to main content
. Author manuscript; available in PMC: 2019 Apr 23.
Published in final edited form as: Discov Med. 2013 Apr;15(83):231–241.

Table 2.

Measures of Adherence.

Measure Pros Cons
Direct
 Direct observation Most accurate Not feasible in real-world practice
 Serum drug levels Objective measure of recent exposure to drug Can be manipulated; acceptable ranges often unknown; assays not widely available
Indirect
 Pill counts Inexpensive Difficult in real-world practice; easy to manipulate; may overestimate adherence; demeaning
 MEMS (microelectronic event monitoring system) Accurate data on when one opens the bottle; may be combined with reminder systems Not easily feasible in real-world practice; expensive
 Refill records Objective higher level data; good for research purposes Report fill rate and not actual intake; impractical for daily use
 Biomarkers May be important intermediaries to outcomes (e.g., hypertension with TKI use) Few developed and validated
 Outcomes Most important variable Difficult to discern nuances of adherence outside of clear extremes
Indirect and Subjective
 Self-report Quick; can use past validated instruments; does not require clinician time Subject to significant bias such as the Hawthorne effect and overestimates adherence
 Assessment by others Inexpensive; allows for a dialogue Hawthorne effect; time consuming
 Diaries Inexpensive; actively involves the patient Subject to manipulation; demeaning; time consuming